Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation

Clin Transplant. 2011 Mar-Apr;25(2):297-301. doi: 10.1111/j.1399-0012.2010.01252.x.

Abstract

Background: The clinical presentation of hepatic artery thrombosis (HAT) post-liver transplantation (LT) varies considerably. Doppler ultrasonography (Doppler US) is the first line investigation, with a diagnostic sensitivity for HAT as high as 92%. Because indocyanine green (ICG) elimination from the blood depends among other factors on the hepatic blood flow, we hypothesized that plasma disappearance rate of indocyanine green (PDR-ICG) can be influenced by the flow in the hepatic artery. Thus, we evaluated the role of PDR-ICG measurement in HAT diagnosis in post-LT patients.

Patients and methods: Fourteen liver transplant patients with no visible flow in the hepatic artery (Doppler US) were identified. Of the 14, seven patients had HAT confirmed by CT-angiography. The PDR-ICG measurement, an investigation routinely used in our center, was performed in all 14 patients.

Results: The PDR-ICG in patients with HAT was significantly lower than in patients without HAT (5.8 ± 4.3 vs. 23.8 ± 7.4%/min, p= 0.0009). In patients with HAT, after the revascularization, the PDR-ICG value increased (5.8 ± 4.3 vs. 15.6 ± 3.5%/min, p = 0.006).

Conclusion: The ICG elimination may be an adjunct diagnostic tool in the management of patients with suspected HAT following LT.

MeSH terms

  • Adult
  • Coloring Agents* / pharmacokinetics
  • Female
  • Graft Rejection / prevention & control
  • Graft Survival
  • Hepatic Artery / pathology*
  • Humans
  • Indocyanine Green* / pharmacokinetics
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Postoperative Complications*
  • Thrombosis / diagnosis*
  • Thrombosis / etiology
  • Thrombosis / therapy
  • Tissue Distribution
  • Treatment Outcome
  • Ultrasonography, Doppler

Substances

  • Coloring Agents
  • Indocyanine Green